Table 5.
Statistical Analysis.
| mRS ≥ 5 | mRS <5 | p value | ||
|---|---|---|---|---|
| n | 5 | 4 | ||
| Age (years) | 69.2±17.1 | 60.5±14.2 | 0.485 | |
| Use of immunosuppressant (n) | 3 | 2 | 0.841 | |
| Opening pressure >300 mmH2O (n) | 4 | 1 | 0.527 | |
| CSF white cell count (/μL) | 48.2±49.9 | 342.9±145.1 | 0.011 | |
| Duration to start treatment (weeks) | 5.8±2.23 | 3.75±1.79 | 0.229 | |
| Positive CSF culture (n) | 4 | 1 | 0.271 | |
| Acute phase treatment period (weeks) | 5.8±1.83 | 12±12.27 | 0.358 | |
| Period of negative conversion (days) | CSF culture | 11.0±6.54 | 3.5±6.06 | 0.163 |
| India ick staining | 52.2±31.10 | 5.33±7.54 | 0.126 | |
| Relapse (n) | 3 | 2 | 0.841 | |
| Final cryptococcal antigen titer in CSF >1:128 (n) | 3 | 0 | 0.083 | |
CSF: cerebrospinal fluid, mRS: modified Rankin Scale